Clinical InvestigationsNovel plasma biomarkers predicting biventricular involvement in arrhythmogenic right ventricular cardiomyopathy
Under a Creative Commons license
open access
Graphical abstractAU: Please provide the all author(s) degree. Novel biomarkers in ARVC, Plasma levels of sST2 and GDF-15 are elevated in ARVC patients with biventricular (BiV) involvement and these biomarkers are correlated with adverse heart failure outcomes, whereas Gal-3 levels are elevated in patients with and without BiV involvement. The combined use of sST2, GDF-15 and NT-proBNP showed the best prediction of BiV involvement in ARVC.
Graphical abstract
Novel biomarkers in ARVC, Plasma levels of sST2 and GDF-15 are elevated in ARVC patients with biventricular (BiV) involvement and these biomarkers are correlated with adverse heart failure outcomes, whereas Gal-3 levels are elevated in patients with and without BiV involvement. The combined use of sST2, GDF-15 and NT-proBNP showed the best prediction of BiV involvement in ARVC.
.
Keywords
Arrhythmogenic cardiomyopathy
Right ventricular
Biomarker
Heart failure
Risk stratification
Cited by (0)
- #
Deniz Akdis and Liang Chen are shared first authors
- $
Firat Duru and Jiangping Song are shared senior authors
© 2021 The Authors. Published by Elsevier Inc.